These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

910 related articles for article (PubMed ID: 12053947)

  • 21. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(224):64556-88. PubMed ID: 10339052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical devices; device tracking--FDA. Final rule; suspension of effective date; notification of status under the Safe Medical Devices Act; technical amendments.
    Fed Regist; 1993 Aug; 58(156):43442-51. PubMed ID: 10127886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical devices; medical device, user facility, distributor, and manufacturer reporting, certification, and registration; correction--FDA. Tentative final rule; correction.
    Fed Regist; 1992 Feb; 57(37):6486-7. PubMed ID: 10117356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical devices; reports of corrections and removals--FDA. Final rule.
    Fed Regist; 1997 May; 62(96):27183. PubMed ID: 10167533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep; 63(188):51874-5. PubMed ID: 10185813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Aug; 63(166):45716-7. PubMed ID: 10182694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical devices; gastroenterology-urology devices; nonimplanted, peripheral electrical continence device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(68):18236-7. PubMed ID: 11010624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
    Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. US and European postmarket clinical data requirements.
    Donawa M
    Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical devices; classification for medical washer and medical washer-disinfector. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Nov; 67(221):69119-21. PubMed ID: 12437015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(71):19650-8. PubMed ID: 11010632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical devices; immunology and microbiology devices; classification of the immunomagnetic circulating cancer cell selection and enumeration system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 May; 69(91):26036-8. PubMed ID: 15137395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who should protect the public? The Supreme Court and medical device regulation.
    Korobkin R
    N Engl J Med; 2007 Oct; 357(17):1680-1. PubMed ID: 17960010
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical devices; device tracking. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Feb; 67(27):5943-52. PubMed ID: 11838471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical Devices; hematology and pathology devices; reclassification of automated blood cell separator device operating by filtration principle from class III to class II. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(40):9530-2. PubMed ID: 12617085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical devices; medical device distributor reporting; opportunity for comments--FDA. Final rule; opportunity for comments.
    Fed Regist; 1993 Sep; 58(168):46514. PubMed ID: 10128334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Final rule.
    Fed Regist; 1998 Oct; 63(195):54042-4. PubMed ID: 10185825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical devices; medical device user facility and manufacturer reporting, certification and registration; Office of Management and Budget approval; extension of effective date--FDA. Final rule; notification of approval of information collection requirements.
    Fed Regist; 1996 Apr; 61(71):16043-5. PubMed ID: 10157704
    [No Abstract]   [Full Text] [Related]  

  • 40. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.